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Summary
Objectives: In this study, the effect of maternal peripheral and placental Plasmodium
falciparum parasitaemia on the level of antibody and cytokine immune responses in
the neonate was investigated.
Methods: Malaria parasites were detected by light microscopy. Levels of malaria-
specific isotypic antibodies were measured in maternal and cord blood by indirect
ELISA. The numbers of IFN-g and IL-4 cells produced by maternal/cord blood after in
vitro stimulation were enumerated using the ELISPOT assay.
Results: Malaria parasite rate of maternal, placental biopsy and cord blood was
32.8%, 33.7% and 7.8% respectively. Overall, ELISA seropositivity rates for P. falci-
parum-specific IgG, IgM, IgE and IgA in the maternal plasma samples were 71%, 85%,
29.3%, and 0% respectively, while those for the cord samples were 69%, 6.0%, 4.4% and
0% respectively. Mean IgM ELISA OD405 values of neonates born from positive pla-
centas, or whosemothers had peripheral malaria parasitaemia were higher than those
who were parasite negative. The mean number of maternal cells producing IFN-g was
higher (P = 0.0001) than that of the paired cord samples. The mean number of IL-4
producing cells of neonates born of mothers who were positive (P < 0.05) or from
malaria-positive placentas (P < 0.025) was higher than from those who were malaria
negative. Neonates born of malaria-positive mothers or from parasitized placentas
mounted predominantly Th2 type immune responses.
* Corresponding author. Tel.: +237 3322134/3323101; fax: +237 3322272.
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Conclusion: It appears from this study that neonates born from malaria-infected
mothers or placentas may relatively be more susceptible to malaria attack during the
first years of life.
# 2005 International Society for Infectious Diseases. Published by Elsevier Ltd. All
rights reserved.Introduction
In malaria-endemic areas, exacerbation of malaria
due to Plasmodium falciparum in association with
pregnancy, particularly among primigravidae, has
been reported.1 This observation is thought to be,
in part, the result of the general immune ‘dampen-
ing’ during pregnancy.2 However, the degree of
susceptibility and the clinical severity during preg-
nancy are not uniform, varying from one region
where falciparum malaria is hyperendemic to
another low endemic zone.3 This variability has
been attributed amongst other things to differences
in natural immune factors such as blood polymorph-
isms, and acquired immune factors between popu-
lations.4
Women in malaria meso- to hyperendemic areas
have high naturally-acquired immunity and are
usually asymptomatic to malaria parasite infec-
tion.5 Among semi-immune women, severe syn-
dromes such as cerebral malaria and pulmonary
oedema frequently occur.6 Maternal malaria is asso-
ciated with poor foetal outcomes such as stillbirths,
abortions and low birth weight infants which are at a
higher risk of dying early in life.7 Human placenta
has a predilection for malaria parasites and since
maternal and foetal tissues within the placenta are
intimately associated, parasite antigens can cross
the placental barrier and influence the immune
response of the foetus. Malaria parasites have been
detected in the cord blood of infants born to
infected mothers8,9 but have rarely been detected
in blood samples obtained by finger prick from
neonates (congenital malaria) suggesting that the
parasite elicits foetal pathology through other med-
iators.
Plasmodium falciparum-specific immunoglobulin
M, IgG and IgE antibodies have been demonstrated in
the sera of malaria patients and inhabitants of
malaria-endemic areas.10,11 It is generally known
that only IgG crosses the placenta to passively
establish a nearly equal titre in cord blood.12,13
However, higher IgG levels have been reported in
maternal compared with cord sera in Africans.14—16
IgM does not cross the placenta, but has been
detected in cord blood.14,15 In African cord sera,
there are some reports which suggest in utero IgAsynthesis.15,17 However, in Nigerian newborns18 and
in Caucasian cord sera19 IgAwas not detected. There
is a need therefore to conductmore studies aimed at
determining the distribution of malaria-specific iso-
typic antibodies between mother and newborn and
investigate how this distribution is affected by
malaria parasitaemia and parity. Raised levels of
P. falciparum-specific antibodies have been asso-
ciated with resistance to malaria.20 In other studies,
markedly raised levels of IgE were associated with
the pathogenesis of severe malaria as IgE containing
immune complexes or aggregates were shown to
induce TNF-a production by monocytes and other
effector cells through cross-linking of CD23 recep-
tors.21,22
Previous studies observed that the immune sys-
tem of the pregnant woman is biased towards anti-
body production and away from cell-mediated
immunity.23,24 It has been suggested that Th2 cyto-
kines (anti-inflammatory cytokines) down regulate
Th1 cytokine responses (pro-inflammatory) thus
protecting the foetus from rejection25 but also
increasing the incidence of several infectious dis-
eases that are usually under control of CD4+ T
lymphocytes.
Early gestational exposure of an immature foetal
immune system to exogenous antigens can induce
immunological tolerance which could increase
future susceptibility to infection.26 Conversely, late
gestational exposure can prime immune responses
prior to birth27 and improve responses to future
vaccination.28
As a sequel to inconsistent findings as regards
the level of transplacental IgG and the presence of
IgM and IgA in cord blood, this study investigated
the distribution of malaria-specific isotypic antibo-
dies and the possible effects of maternal or pla-
cental malaria parasitaemia on the level of
transplacental transfer of antibodies in the new-
born. In the present study the cytokine responses
have been compared to crude P. falciparum anti-
gens (MA) of cord blood samples obtained from
mothers with or without peripheral and placental
malaria parasitaemia using the ELISPOT assay to
determine whether in utero exposure to P. falci-
parum modifies the neonates’ immune response to
malaria infection.
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Study site and population
This study was carried out at the Mutengene mater-
nity centre located in a semi-urban community in
Fako Division, South West Province, Cameroon.
Mutengene maternity centre provides basic health
care services such as immunization of children,
prenatal surveillance, delivery services and family
planning to a population of 11,500 inhabitants who
are mainly peasant farmers and traders. This semi-
urban town is located in a forest zone and is about
300 m above sea level. Mean annual temperature
and rainfall are about 20 8C and 2625 mm respec-
tively. Malaria transmission in Fako Division is per-
ennial although it is more intense during the rainy
season with peak transmission between July—August
and October—November. The main vector for
malaria parasite transmission is Anopheles gam-
biae29 and P. falciparum is the predominant malaria
parasite accounting for up to 96.8% of malaria infec-
tions in the study area.30
The study population consisted of indigenous
volunteer full-term pregnant women reporting for
delivery at the Mutengene maternity centre. Blood
samples were collected at delivery from the umbi-
lical cords of neonates by compression and from the
parturient women by venepuncture within 18 hours
of delivery after obtaining informed consent. A total
of 627 paired maternal cord samples were collected
from single deliveries between March 1999 and June
2001. After delivery of the placenta, a biopsy was
obtained from the maternal side and immediately
transported to the laboratory where it was rinsed in
PBS and incised. Impression smears were then pre-
pared on three glass slides for parasitologic exam-
ination. Plasma separated from the paired maternal
and cord samples was stored at 20 8C until ana-
lysed for malaria-specific isotypic antibodies. One
hundred paired randomly selected maternal cord
blood samples were used for the ELISPOT assay. All
the parturient women were of the same socio-eco-
nomic status and their mean age (years, SD) was
22.76  4.84 (age range: 13—44 years).
Parasitologic examination
Thin and thick blood smears of maternal peripheral
or cord blood and impression smears of placental
biopsies were stained with Giemsa (Sigma, St Louis,
USA) and examined under oil immersion for para-
sites. Microscopic examination for the detection of
malaria parasites was made in 200 high power fields
before being considered negative. A mother or neo-
nate was considered to have malaria infection if anyasexual blood stage parasites were seen on a thick
smear of maternal or umbilical blood respectively.
For maternal peripheral and cord blood samples,
malaria parasites were counted against leucocytes,
assuming a constant leucocyte count of 8000 per
microlitre of blood.31 Malaria parasite-infected red
blood cells were counted against erythrocytes in
order to determine the percentage of malaria para-
sitaemia for placental biopsy smears. Placental
infection status was categorized as infected (pre-
sence of any asexual parasite stages in the placenta)
and non-infected (parasite negative smear). Smears
with malarial pigments but with no asexual stage
parasites were declared as unknown and were not
included in the analysis.
Antigens
The F32 Tanzanian strain of P. falciparum was cul-
tured in vitro to more than 10% parasitaemia with
over 70% of the parasites at the schizont stage. The
culture was schizont enriched by percoll gradient
centrifugation. The schizont-enriched fraction was
sonicated to yield the crude P. falciparum antigen
(MA). This preparation was used at a concentration
previously shown not to induce any proliferative
response in malaria non-exposed donors (5 mg/
ml). As control antigens, sonicates of normal unin-
fected erythrocyte ghosts were used.32 Phytohae-
magglutinin (PHA) was used as a non-specific
stimulating agent. All the stimulants were used at
a final concentration of 5 mg/ml.
ELISA seroreactivities to crude blood stage
antigens of P. falciparum
Plasmodium falciparum-specific anti-IgG, IgM, IgE
and IgA antibodies were measured by ELISA using
total blood stage parasite extract (MA) as capture
antigen. ELISA for the determination of isotypic
malaria-specific antibodies was carried out using
the method described by Perlmann et al.33 The Ig
antibodies were measured using goat anti-human
IgG (Fc-g specific), IgM (m-chain specific), IgA (m-
chain specific) purchased from Sigma, Saint Louis,
USA. Malaria-specific IgE was measured using affi-
nity purified rabbit IgG antibodies specific for human
IgE (5 mg/ml; Miab, Uppsala, Sweden). From check-
erboard titration, it was determined that the opti-
mal concentration for coating the crude blood stage
antigens was 10 mg/ml for all isotypes while the test
plasma were screened at a 1/200 dilution for IgG, 1/
100 for IgM and 1:50 for IgA and IgE. Microtitre plates
(Corstar, Cambridge, MA) were incubated overnight
at 4 8C with the MA in carbonate buffer (50 ml/well)
and then blocked for three hours at 37 8C with
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Bovine Serum Albumin (BSA). Duplicate wells were
subsequently incubated with 50 ml/well of test
serum in PBS—0.5% Tween 20 (paired maternal cord
samples were assayed in the same plate) and isotype
specific anti-sera conjugated to alkaline phospha-
tase (ALP). All incubations were carried out at 37 8C
for 1 hour. Since detection of IgE antibodies in the
presence of excess IgG antibodies requires pro-
longed interaction times,10 overnight incubation
was at room temperature. Bound IgE was assayed
with biotinylated, IgE-specific rabbit antibodies fol-
lowed by ALP-conjugated streptavidin (Mabtech,
Stockholm, Sweden) as described in detail by Perl-
mann et al.10 Para-nitrophenol phosphate (Sigma, St
Louis, USA) was added and the absorbance at a
wavelength of 405 nm (OD405) read with a multiscan
ELISA plate reader. Test samples with OD405 values in
excess of the mean + 2SD of the values of 25 non-
immune Swedish donors were defined as seroposi-
tive.
Cell cultures
Peripheral blood mononuclear cells (PBMC) and cord
blood mononuclear cells (CBMC) were isolated from
maternal and cord blood samples respectively by
Ficoll-paque (Pharmacia LKB Biotechnology AB) den-
sity gradient centrifugation previously described.32
The PBMCs/CBMCs were resuspended at a cell con-
centration of 2  106/ml in tissue culture medium
(TCM) consisting of HEPES-buffered RPMI-1640
(Sigma, Saint Louis, USA). Cell cultures were main-
tained in small culture tubes (4 ml, Falcon) in the
presence of the different antigens or the mitogen
and incubated for 3—4 hours. Control cultures com-
prised cells cultured in the absence of any antigen or
mitogen.
Enumeration of IL-4 and IFN-g secreting cells
IFN-g and IL-4 secreting cells were detected by the
ELISPOT assay as described by Elghazali et al.34 In
brief, 100 ml of TCM containing 2  105 PBMC/CBMC
(pre-cultured in the presence or absence of MA or
mitogen for 3—4 hours) were dispensed into tripli-
cate wells of nitrocellulose-bottomed plates (Milli-
pore Co, Bedford, MA) precoated with anti-IFN-g
MoAb 1-DIK or anti-IL-4 MoAb 82-4 (15 mg/ml) (Mab-
tech AB, Stockholm, Sweden). After incubation for
36—40 hours, the cells were removed by washing the
wells three times with PBS at a pH of 7.2. After
blotting out excess PBS, the plates were then incu-
bated for 2 hours with biotin-conjugated antibody
(MoAb 7-B6) for IFN-g or MoAb 12-1 for IL-4. The
plates were then washed and incubated with strep-tavidin-alkaline phosphatase (Mabtech) for 1 hour.
After washing, 100 ml of the enzyme substrate solu-
tion BCIP/NBT (BioRad Labs, Richmond, CA) were
added until spots were detectable, usually after
30—60 minutes. The colour reaction was stopped
by extensive washing under running tap water. After
drying, the spots were enumerated under low mag-
nification (40) using a dissection microscope. The
number of cytokine-producing cells was expressed
per 2  105 PBMC/CBMC. Antigen induced IL-4 and
IFN-g responses were considered positive if the
number of spots were greater than the mean + 2SD
of that in the antigen-free wells for each of the test
samples.
Statistical analysis
Comparison of the group means was carried out
using the unpaired Student’s t-test. Differences in
rates were assessed by chi-square, chi-square for
trend or Fisher’s exact tests. A linear relationship
between two variables was analysed by linear
regression or Spearman rank correlation test. Sta-
tistical significance was designated as P < 0.05.Results
Malaria parasitaemia at delivery
Malaria parasites were found on peripheral thick
blood films of 205 of the 627 parturient women
(32.7%) while cord blood parasitaemia was detected
in 48 cases (7%). The placental malaria parasite rate
was 33.6% (211/627). Placental (P = 0.0001) and
peripheral (P = 0.025) malaria parasite rates were
significantly higher in primiparae when compared
with their multiparae counterparts.
Plasmodium falciparum-specific
immunoglobulins in paired cord and
maternal samples
Plasmodium falciparum-specific IgG seropositivity
rates in paired cord-maternal sera were similar
(P > 0.05). In contrast, IgM (P = 0.0001) and IgE
(P = 0.0001) seropositivity rates were higher in
maternal than in cord samples (Figure 1). None of
the paired plasma samples were seropositive for
malarial-specific IgA antibodies (data not shown).
A significant positive correlation was obtained
between maternal and cord IgG (r = 0.815; P =
0.0001) but neither with IgM (r = 0.189; P = 0.2993)
nor with IgE levels (r = 0.096; P = 0.413). While mean
ELISA OD405 values for IgG were similar in paired cord
andmaternal samples, mean IgM and IgE ELISAvalues
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Figure 1 ELISA seropositivity rates of immunoglobulin
isotypes (IgG, IgM and IgE) to crude Plasmodium falci-
parum antigens in paired maternal cord sera.were significantly higher in maternal than in cord
blood (Table 1).
Maternal peripheral and placental malaria para-
sitaemia did not significantly influence IgG, IgM and
IgE seropositivity rates in cord andmaternal samples.
Similarly, mean ELISA OD405 values for IgG and IgE
levels (ng/ml) of paired cord-maternal samples were
not significantly different between malaria parasite
positive placentas or mothers and those who were
malaria negative. However, themean IgMELISAOD405
values of neonates born from malaria-positive pla-
centas or from mothers who had peripheral malaria
parasitaemia were significantly higher than those
who were parasite negative (Table 2). Maternal IgGTable 1 Mean (SD) ELISA IgG and IgM ELISA OD405 values
Ig Isotype Mother C
n Mean (SD) n
IgG (OD405) 444 0.384  0.48 4
IgM (OD405) 472 0.292  0.29
IgE (ng/ml) 41 5287  4542
Table 2 Mean (SD) ELISA IgG, IgM OD405 values and IgE
maternal parasitaemia status.
IgG
n Mean (SD)
Placenta
Malaria positive 131 0.333  0.42
Malaria negative 278 0.301  0.19
Significance level t = 0.301; P = 0.763
Mother
Malaria positive 131 0.305  0.36
Malaria negative 281 0.350  0.42
Significance level t = 1.058; P = 0.291(x2 = 2.53; P = 0.080) and IgM (x2 = 1.203; P = 0.273)
seropositivity rates were not significantly different
between primiparae and multiparae (Figure 2). In
contrast,multiparaehadhighermean IgGELISAOD405
values than primiparae (Table 3).
Frequency of mitogen- or antigen-induced
cytokine-secreting cells
The enzyme linked immunospot (ELISPOT) assay was
used in this study to determine the number of IFN-g
and IL-4 producing cells in 100 paired maternal cord
blood samples after in vitro stimulation with PHA or
crude blood stage antigen of P. falciparum (MA).
After stimulation with PHA, all the mothers and 88%
of the paired cord samples responded positively to
IFN-g production. Similarly, 79% of mothers and 52%
of cord blood samples responded positively (after
PHA stimulation) to IL-4 production. There was no
significant difference in the number of IL-4
(P > 0.05) and IFN-g (P > 0.05) producing cells
between malaria positive and negative mothers
following mitogenic stimulation. The number of
IL-4 and IFN-g producing cells of neonates born to
mothers with malaria or placental parasitaemia
were not statistically different from those without
malaria parasitaemia.
Following stimulation with MA, the numbers of
cytokine-producing cells were more reduced than
after PHA stimulation. The MA stimulated maternal
PBMCs resulted in more cells producing IFN-g than
IL-4 while there was no difference with the CBMCs
(Table 4). Following stimulation with MA there wasand IgE levels (ng/ml) of paired maternal cord samples.
ord Significance level
Mean (SD)
07 0.333  0.39 t = 1.700; P > 0.05
32 0.104  0.12 t = 3.662; P = 0.001
44 701  425 t = 8.741; P = 0.0001
levels (ng/ml) of cord blood samples and placental or
IgM IgE
n Mean (SD) n Mean (SD)
8 0.188  0.18 16 648  739
23 0.078  0.09 27 739  421
t = 2.148; P = 0.041 t = 0.669; P = 0.507
7 0.229  0.19 21 790  619
26 0.076  0.07 21 619  337
t = 3.408; P = 0.002 t = 1.295; P = 0.202
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Figure 2 ELISA seropositivity rates of immunoglobulin
isotypes (IgG, IgM and IgE) to crude Plasmodium falci-
parum antigens in primigravidae and multigravidae.
Table 3 Mean (SD) ELISA IgG and IgM OD405 values and IgE
delivery.
Ig Isotype Primigravidae Mu
n Mean (SD) n
IgG 159 0.311  0.42 27
IgM 171 0.277  0.27 28
IgE 14 5524  4101 2
Table 5 Mean (SD) number of IFN-g and IL-4 producin
Plasmodium falciparum by ELISPOT assay in neonates born
or negative.
Number of cytokine spots/200,000 cells
Malaria positive M
n Mean  SD n
Mother
IL-4 18 10.9  4.3 23
IFN-g 18 7.5  3.3 23
Placenta
IL-4 18 9.7  3.2 23
IFN-g 18 6.9  2.8 23
Table 4 Mean (SD) number of IFN-g and IL-4 producin
Plasmodium falciparum stimulation in vitro by ELISPOT assa
Mean number of cytokine spo
IFN-g Mean  SD
Mother 12.6  5.8 (63%)
Cord 7.1  2.3 (29%)
Significance level t = 4.919; P = 0.0001
Values in parentheses indicate the percentage of positive cytokineno correlation in the number of IL-4 (n = 34;
P > 0.05) and IFN-g (n = 29; P > 0.05) producing
cells betweenmaternal and cord samples. Themean
maternal IL-4 and IFN-g producing cells of parasi-
taemic and aparasitaemic mothers at delivery were
similar. The mean number of IL-4 producing cells of
neonates born of mothers whose peripheral blood
had malaria parasites (P < 0.05) or whose placentas
were positive for malaria parasites (P < 0.025) were
significantly higher than from those who were
malaria negative (Table 5).
Ratio of IFN-g/IL-4 cytokine producing cells
IFN-g production was used as a measure of Th1
responsiveness and IL-4 production was used as a
measure of Th2 responsiveness. To enable the com-
parison of functional Tcell heterogeneity, the ratio of
IFN-g to IL-4 producing cells was determined. Thus
when this ratio was greater than 1 then there was a
shift towards Th1 immune responses, while a ratiolevels (ng/ml) of primigravid and multigravid women at
ltigravidae Significance level
Mean (SD)
4 0.422  0.49 t = 2.394; P = 0.0171
6 0.305  0.29 t = 0.992; P = 0.3216
6 5037  4876 t = 0.318; P = 0.7524
g cells in response to crude blood stage antigens of
from mothers or placentas which were malaria positive
Significance level
alaria negative
Mean  SD
8.1  3.6 t = 2.269; P < 0.050
6.9  2.7 t = 0.549; P > 0.500
7.4  2.8 t = 2.452; P < 0.025
7.1  3.2 t = 0.209; P > 0.500
g cells in response to crude blood stage antigens of
y in paired maternal cord blood samples.
ts/200,000 cells Significance level
IL-4 Mean  SD
9.2  4.3 (41%) t = 3.219; P = 0.005
8.5  3.1 (34%) t = 1.050; P > 0.05
t = 0.793; P = 0.4987
responders in 100 paired maternal cord blood samples.
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Figure 3 Percentage of Th2 responders (IL-4 secretors
after stimulation with crude malaria antigen) in neonates
born from mothers and placentas who were malaria posi-
tive or negative.less than 1 indicated a shift towards Th2 immune
responses. The number of IL-4 and IFN-g producing
cells varied greatly amongst thepairedmaternal cord
samples. Stimulation of maternal and cord cells with
MA produced two groups of responders: those with
Th1 and others with Th2 responses. Neonates born
of malaria-positive mothers (P = 0.0253) or from
parasitised placentas (P = 0.0214)mounted predomi-
nantly Th2 type immune responses after stimulation
with MAwhen compared with their malaria parasite-
negative counterparts (Figure 3) (P = 0.0253 and
P = 0.0214 for parasitised mothers and placentas
respectively). In addition, neonates born of primi-
gravidae elicited higher rates of Th2 responses when
compared to neonates born of multigravidae (68% vs.
33%; P = 0.036).Discussion
This report confirms and extends previous results of
low parasite rates and density in cord blood35,36 and
confirms that primiparae are more susceptible to
malaria infection compared with multiparae.1,8 In
addition, the detection of IgM and IgE specific to P.
falciparum in some cord sera provides evidence that
foetuses by themselves can mount humoral immune
responses when challenged with malaria antigens.
Malarial-specific IgG, IgM and IgE antibodies have
been detected in immune individuals inhabiting
malaria endemic areas.37—39 While the occurrence
of IgM in cord blood has been documented, there
have been limited studies on the presence of other
isotypes and the specificity of the Igs detected. In
Gabon, P. falciparum-specific IgM in was detected in
11.9% of cord serum.38 They suggested that the
prenatal immune sensitization leading to IgM pro-
duction by the foetus was facilitated by malaria-related histopathological changes. Also in Yaounde,
Cameroon, malarial-specific IgM was identified in
14% of cord samples.40 In contrast, in Papua New
Guinea, P. falciparum-specific IgM was not detected
in 46 cord samples while 13.3% were positive for IgE
antibodies.41 Maeno et al. found that IgE deposits
have been demonstrated in foetal blood vessels and
it was observed that the amount of deposition of IgE
in the placenta from women infected with P. falci-
parum was inversely correlated with the degree of
parasitaemia at that site.42 In the present study, the
presence and level of maternal parasite-specific IgG
in cords reflected the presence and level of para-
site-specific IgG. As IgG crosses the placenta, a
correlation between maternal and cord malarial
IgG was anticipated. In contrast, cord level seropo-
sitivity and the level of malarial-specific IgM and IgE
were lower than maternal levels, suggesting that
the foetus produces these antibodies in utero in
response to antigenic challenge. How these antigens
gain access into foetal circulation remains to be
clearly elucidated. Histopathological changes to
the placenta as previously suggested38 may allow
the passage of malarial antigens from maternal into
foetal circulation. Maternal and foetal tissues within
the placenta are intimately associated and it is
possible therefore that malarial infection within
maternal tissues would result in malaria antigens
crossing over into the foetal circulation. Further-
more, soluble malaria antigens have been detected
in cord blood.43 Antibodies against total blood stage
antigens reflect exposure to malaria infection and
the results here indicate a high level of exposure to
the parturient women, which is mirrored by the high
level of transplacental transfer of malarial antibo-
dies found in cord blood.
There are conflicting reports regarding the pre-
sence of IgA in cord sera. Low levels of IgA have been
demonstrated in cord sera15,17 while IgA was not
detectable in Nigerian newborns.18,36 In the present
study malarial-specific IgA was not detected in any
of the cord and maternal samples tested.
Also in the present study, cord blood malarial-
specific IgG and IgE levels were not affected by the
presence of malaria parasites in the mother or the
placenta. However, children born of mothers with
peripheral or placental malaria parasitaemia pro-
duced more IgM antibodies than those from
malaria-negative mothers. A substantial increase in
IgM levels in subjects with acute falciparum malaria
has been reported.44,45 However, in another study
IgG, IgM and IgA levels were observed to increase
simultaneously.46 Higher levels of malarial-specific
IgG and IgM have been demonstrated in more P.
falciparum-infected adults than falciparum non-
infected adults.47
166 E.A. Achidi et al.In general, the presence of malarial-specific IgG,
IgM and IgE antibodies was not dependent upon the
parity of themother. However, multiparae tended to
produce more malarial-specific IgG antibodies while
IgM and IgE antibody levels were similar in both
parity groups. The raised levels of IgG antibodies
may be related to the age of the mothers (who were
older) as these antibodies have been shown to
increase with number of exposures and age.48
Previous studies have clearly demonstrated that
human foetuses of malaria parasite-infected
mothers or parasitized placentas are exposed to
parasite antigens8,41 and/or parasite-specific anti-
idiotypes49 in utero and which are able to sensitise
the foetal immune response.36 Some studies inves-
tigating the effect of in utero exposure to parasites
on the cellular immune responses demonstrated an
overall hyporesponsiveness to specific parasite anti-
gens in neonates born to infected mothers.50—52 The
ability to mount an anamnestic response to pre-
viously encountered antigens is a fundamental prop-
erty of the immune system. Overall, the results here
indicate that maternal peripheral or placental
malaria parasitaemia may lead to a bias in the
immune responses of their neonates towards a
Th2-type response. Previous epidemiological studies
have demonstrated that in utero exposure to filarial
antigens53 or Onchocerca volvulus54 resulted in the
production of predominantly Th2 cytokines to para-
site antigens, increased susceptibility to infection
and higher levels of infection in the offspring. In a
similar study investigating the cytokine responses of
CBMCs to different allergens, it was shown that
virtually all the newborns mounted a Th2-skewed
response to common environmental allergens with
IL-10 being the highest cytokine produced.55 It has
been observed that infants born from malaria para-
site-infected placentas were more likely to develop
malaria infection between four and six months of
age.56 They also reported that malaria parasitaemia
prevalence rates were higher in placenta-infected
infants from five to eight months of age thus sug-
gesting that malaria infection of the placenta may
result in a higher susceptibility of infants to the
parasite probably due to their inability to mount a
strong Th1 response.
In this study it was observed that neonates born of
primigravidae elicited higher rates of Th2 responses
when compared to neonates born of multigravidae.
In malaria endemic areas it is generally known that
the prevalence and density of malaria infection is
highest in primigravidae when compared with multi-
gravidae. It has also been shown that in primigra-
vidae, an elevation of placental IFN-g in concert
with raised TNF-a levels and possibly IL-2 were
associated with poor outcomes for both motherand newborn. The raised prevalence of Th2 respon-
ders amongst primigravidae may be due to the
increased frequency and density of malaria infec-
tion in this vulnerable group in malaria endemic
areas.
It has been suggested that normal pregnancy is
characterized by a lack of strong maternal cell-
mediated anti-foetal immunity and a dominant
humoral immune response or that Th1-type immunity
is incompatible with a successful pregnancy.57,58
Cytokine concentrations weremeasured in placentas
obtained fromwomen delivering in amalaria holoen-
demic and non-endemic area.59 They observed that
pro-inflammatory cytokines were absent from the
placentas from malaria non-endemic areas but were
present in large proportions in placentas from the
holoendemic area. They concluded that maternal
malaria decreases IL-10 levels and elicits IFN-g, IL-
2 and TNF-a in the placenta, shifting the balance
towards type 1 cytokines. In The Gambia, raised
levels of pro-inflammatory cytokines (Th1 responses)
were also reported in most placentas analysed when
comparedwith peripheral blood and it was suggested
that these inflammatory reactions regulated parasite
replication in the placenta butmay also contribute to
placental pathology.60 However, in this study, raised
levels of IL-10, an anti-inflammatory cytokine were
obtained in P. falciparum-infected placentas. It
appears therefore that the predominantly Th1
responses in parasitized placentas induced the
production of IL-10 which may suppress the
cellular reactions that may result in a pathological
placenta. Therefore, it appears that malaria para-
sitized mothers or placentas express Th1-type cyto-
kines,which cross the placenta repeatedly and prime
the immune system of the foetus towards Th1
responses.
Maternal and foetal tissues within the placenta
are intimately associated. It might therefore be
expected that malarial infection within maternal
tissues would result in malaria antigens crossing
over into the foetal circulation. Soluble malaria
antigens have been detected in cord blood.40 It
appears that the bias to Th2-type responses, typical
of asymptomatic malaria parasitaemia in adults, has
been initiated in utero probably as a result of long
term exposure to the parasite antigens since the
placenta has a predilection for malaria parasite
parasitization. Therefore, a newborn delivered by
an uninfected mother appears to be less susceptible
to malaria attack than a child whose immune system
is already biased to a Th2-type immune response as
a result of in utero exposure to malaria parasites, a
finding consolidated by the detection of P. falci-
parum-specific IgM and Wuchereria bancrofti-spe-
cific IgE in the cord blood of infected mothers.24
Studies on Plasmodium falciparum isotypic antibodies and numbers of IL-4 and IFN-g 167However, there is need for further studies to eluci-
date if the observed Th2 bias is transitory or pro-
longs into the first months of life of the infant.
It may seem that this in utero effect of biasing the
parasite-specific immune response and thus increas-
ing susceptibility to infection would be deleterious
to the infant. However, in many parasitic infections,
including malaria and lymphatic filariasis, some of
the debilitating pathology is immune mediated.
Thus, tolerance induction in uteromay be a suitable
adaptation to life in malaria hyper-endemic areas
where limiting the development of pathology is
advantageous. This is an important issue to consider
when designing control strategies and targeting the
most appropriate vulnerable population in an area
of malaria endemicity.
The findings here demonstrate that foetuses
can mount humoral immune responses against
malarial antigens and that P. falciparum antibodies
are transferred from mothers to newborns and
contribute to the relative protection observed in
young infants. These results also demonstrate
that the immune system of some neonates born
in the study area are primed to malaria antigens
and produce predominantly IL-4 responses upon
antigenic stimulation in vitro. Furthermore, it
has been observed that maternal malaria parasi-
taemia or placental parasitization directed the
foetal T cells to respond further on malaria stimu-
lation by producing predominantly Th2 type
responses. Thus neonates born from malaria-
infected mothers or placenta may be more suscep-
tible to malaria during their first year of life since it
is known that during acute malaria attacks, pro-
inflammatory responses are essential in bringing
down the parasite load. Longitudinal studies aimed
at monitoring the age of onset of malaria infection
or malaria attack during infancy are needed to
validate this observation.Acknowledgements
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